← Browse by Condition
Medical Condition

glioblastoma idh isocitrate dehydrogenase wildtype

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT05765812 Phase 1, Phase 2
Recruiting

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

Enrollment
116 pts
Location
United States, Spain...
Sponsor
Debiopharm International SA
View Trial →